opentargets-database

You can identify potential therapeutic targets by querying target-disease associations through the Open Targets Platform. This approach evaluates gene tractability, safety, and druggability to pinpoint viable drug information and targets for disease research.

To retrieve supporting evidence for target-disease associations, you query the Open Targets Platform. This mechanism gathers genetic, somatic, and drug data to validate the biological link between a potential target and a specific disease.

Yes, you need GraphQL knowledge to query the Open Targets Platform API for drug repurposing. This prerequisite allows you to structure requests to identify existing drugs that could be repurposed for new disease indications.

Yes, you can assess the druggability and safety of genes using Open Targets. The platform evaluates target tractability and safety profiles to help researchers prioritize genes for therapeutic development during target discovery.

The best way to find existing drugs for new disease indications is drug repurposing via the Open Targets Platform. By querying target-disease associations, you can discover existing drug information and identify candidates for novel therapeutic applications.